IRIS
PISATURO, Mariantonietta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.139
AS - Asia 3.994
NA - Nord America 3.774
SA - Sud America 757
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 14.745
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.710
RU - Federazione Russa 3.010
SG - Singapore 1.551
IE - Irlanda 1.291
CN - Cina 765
HK - Hong Kong 765
BR - Brasile 640
DE - Germania 407
IT - Italia 375
UA - Ucraina 316
GB - Regno Unito 286
VN - Vietnam 220
KR - Corea 216
JP - Giappone 150
FI - Finlandia 107
IN - India 105
SE - Svezia 85
TR - Turchia 78
GR - Grecia 77
AR - Argentina 51
FR - Francia 41
AT - Austria 29
BD - Bangladesh 25
CA - Canada 23
PL - Polonia 23
ZA - Sudafrica 23
IQ - Iraq 21
MX - Messico 16
BE - Belgio 15
CO - Colombia 15
PK - Pakistan 15
ID - Indonesia 14
VE - Venezuela 13
EC - Ecuador 11
ES - Italia 11
NL - Olanda 11
MA - Marocco 10
CZ - Repubblica Ceca 9
RS - Serbia 9
IR - Iran 8
PE - Perù 8
AL - Albania 7
LT - Lituania 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
EU - Europa 6
PA - Panama 6
UY - Uruguay 6
JM - Giamaica 5
KE - Kenya 5
PY - Paraguay 5
TN - Tunisia 5
TW - Taiwan 5
BO - Bolivia 4
CL - Cile 4
DO - Repubblica Dominicana 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
SN - Senegal 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CM - Camerun 3
GE - Georgia 3
HN - Honduras 3
IL - Israele 3
LB - Libano 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AU - Australia 2
BB - Barbados 2
BY - Bielorussia 2
CD - Congo 2
CH - Svizzera 2
DK - Danimarca 2
GA - Gabon 2
LV - Lettonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
Totale 14.738
Salva come PNG Salva come JPEG
Città #
Dublin 1.291
Moscow 964
Hong Kong 765
Santa Clara 756
Singapore 595
Jacksonville 474
Chandler 438
Seoul 216
Bremen 178
Princeton 176
Ashburn 150
Roxbury 146
Cambridge 119
Hefei 112
Beijing 105
New York 100
Dallas 96
Ho Chi Minh City 83
The Dalles 82
Ann Arbor 73
Bengaluru 70
Caserta 70
Munich 68
São Paulo 62
Medford 58
Boardman 55
Hanoi 51
Wilmington 46
Los Angeles 42
Naples 41
Woodbridge 39
San Mateo 33
Washington 27
Des Moines 26
Nuremberg 22
Helsinki 19
Warsaw 19
Nanjing 18
Brasília 16
Mountain View 16
Brussels 15
Milan 15
Napoli 15
Rio de Janeiro 15
Vienna 15
Da Nang 13
Jinan 13
Johannesburg 13
Tianjin 13
Düsseldorf 12
Belo Horizonte 11
Biên Hòa 11
Changsha 10
Curitiba 10
Porto Alegre 10
Brno 9
Brooklyn 9
Campinas 9
Frankfurt am Main 9
Guangzhou 9
Istanbul 9
Auburn Hills 8
Aversa 8
Chennai 8
Grafing 8
Rome 8
San Francisco 8
Shenyang 8
Tokyo 8
Zhengzhou 8
Hangzhou 7
Houston 7
Lappeenranta 7
London 7
Stockholm 7
Tashkent 7
Ariano Irpino 6
Baku 6
Caxias do Sul 6
Chicago 6
Haiphong 6
Mauá 6
Santo André 6
Shanghai 6
São Bernardo do Campo 6
Tirana 6
Toronto 6
Ankara 5
Baghdad 5
Boston 5
Cairo 5
Criciúma 5
Falkenstein 5
Itajaí 5
Kunming 5
Lucca 5
Maceió 5
Manaus 5
Nairobi 5
Panama City 5
Totale 8.207
Salva come PNG Salva come JPEG
Nome #
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 167
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 153
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 142
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 136
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 133
Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection 133
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 132
Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression 127
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 126
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 124
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 121
Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2012. Boston, Massachusetts, USA. 117
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 117
733 REACTIVATION OF OVERT AND OCCULT HBV INFECTION IN IMMUNOSUPPRESSIVE SETTINGS Journal of Hepatology 117
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment 115
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infection 113
Absence of occult HCV infection in patients experiencing an immunodepression condition 111
579 CHANGING PATTERN OF HBV GENOTYPES IN ITALY 109
Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study 109
540 IDENTIFICATION OF LAMIVUDINE RESISTANT HBV STRAIN RT204V/I IN ACUTE HEPATITIS B IN ITALY 104
Absence of occult HCV infection in HIV-positive patients 102
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 101
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 98
Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment 97
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 96
Clinical and virological characteristics associated with severe acute hepatitis B 96
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 96
ACUTE EXACERBATION OF CHRONIC HEPATITIS C: CLINICAL PRESENTATION, OUTCOME AND RESPONSE TO ANTI-HCV TREATMENT 96
The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy 95
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 95
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 92
Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors 92
F-6 Efficacy and tolerability of peginterferon a-2a and a-2b in patients with chronic hepatitis C by genotype 1: A meta-analysis 92
A HIGH HBSAG GENETIC COMPLEXITY CAN INFLUENCE HBV IMMUNOGENICITY IN THE SETTING OF ACUTE INFECTION 92
P.216 Molecular analysis of genetic variability and epitope stability in a type 1b recurrent HCV infection 91
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 91
Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases. 89
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: A meta-analysis 89
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 89
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection 89
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 88
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 88
A HIGH GENETIC HETEROGENEITY IN HBsAg CAN AFFECT IMMUNOGENICITY IN ACUTE HEPATITIS B INFECTION 88
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy 88
Bloodstream Infection Due to a VIM-Metallo-β-Lactamase-Producing Klebsiella pneumoniae Treated with Cefiderocol in a Preterm Newborn 86
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B 86
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 86
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 86
Risk and prevention of hepatitis b virus reactivation during immunosuppression for non-oncological diseases 86
Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. 85
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 85
Clinical Presentation, Outcomes, and Response to Therapy Among Patients with Acute Exacerbation of Chronic Hepatitis C. 85
The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. 84
Occult HBV infection in the oncohematological setting. 84
Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy 84
Absence of occult HCV infection in HIV-positive patients 84
Role of genetic polymorphisms in hepatitis C virus chronic infection 83
Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases 83
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 83
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data 82
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient 82
Infezione da HBV in soggetti immigrati: risultati preliminari di uno studio prospettico multicentrico 81
Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B 81
An update on the treatment options for HBV/HCV coinfection 81
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease 80
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 80
Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic 80
Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy 80
T-14 Virological and clinical impact of anti-HBV nucleos(t)ide analogues in cirrhotic patients with HBV-HCV coinfection 80
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 80
CANNABINOID RECEPTOR 2 (CB2) 63 QQ VARIANT IS ASSOCIATED WITH A SEVERE HISTOLOGICAL ACTIVITY INDEX IN PATIENTS WITH CHRONIC HEPATITIS C 80
Epidemiology and management of hepatitis C virus infections in immigrant populations 79
Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment 78
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 78
Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study 77
HBV molecular epidemiology and clinical condition of immigrants living in Italy 77
The association between education level and chronic liver disease of any etiology 77
RITUXIMAB-BASED TREATMENT, HCV REPLICATION AND HEPATIC FLARES 76
Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment 75
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 75
Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection 75
Virological factors associated with failure to the latest generation of direct acting agents (Daa) and re-treatment strategy: A narrative review 75
Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection 75
Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12 75
Management of HBV reactivation in non-oncological patients 75
Clinical and virological characteristics associated with severe acute hepatitis B 75
Efficacy of pegylated interferon alpha-2a AND alpha-2b in patients with genotype 1 chronic Hepatitis C: a meta-analysis 74
Caratteristiche virologiche e cliniche dell’epatite acuta A in soggetti con infezione cronica da HBV e da HCV. 74
Early predictors of clinical deterioration in a cohort of outpatients with COVID-19 in southern Italy: A multicenter observational study 73
Sustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cells 73
Virological and epitope evolution of HCV infection from acute hepatitis C to subsequent episodes of HCV-related acute liver cell necrosis. 73
Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index. 73
Role of occult hepatitis B virus infection in chronic hepatitis C 73
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 73
Changes in HBV molecular epidemiology in acute hepatitis B in neapolitan are: a consequence of HBV mass vaccination and increase immigration. 72
Polimorfismo di IL28b nei soggetti con infezione cronica da HCV con transaminasi persistentemente normali e nei pazienti con epatite cronica da HCV 72
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 72
Role of occult hepatitis B virus infection in chronic hepatitis C 72
A Model to Eliminate Viral Hepatitis Infection in Migrants: A Prospective, Multicenter Study in Southern Italy 71
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 71
Totale 9.131
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.733
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021419 0 0 0 0 0 18 92 79 17 109 88 16
2021/2022913 35 15 2 8 210 13 104 11 23 83 66 343
2022/20232.137 193 56 27 115 299 127 2 102 1.126 15 37 38
2023/2024985 68 23 73 68 350 116 15 26 10 11 48 177
2024/20253.185 9 39 14 86 480 442 395 302 537 460 236 185
2025/20265.990 508 601 655 613 1.094 2.519 0 0 0 0 0 0
Totale 15.065